Article

Rheumatology Network's Top 5: March 26, 2022

Author(s):

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending March 26, 2021.

Rheumatoid Arthritis Quiz: RA Treat-to-Target

Treat-to-target is a key strategy used in the treatment of many chronic conditions. Test your knowledge of its use in rheumatoid arthritis.

Pregnancy Complications More Prevalent in Women With Axial Spondyloarthritis

“Understanding the impact of axSpA on pregnancy outcomes is a vital component of improving management of women with axSpA at every stage of their lives,” investigators stated.

Iberdomide Proven Effective in Treating Patients With SLE

Iberdomide, a high-affinity cereblon modulator, works by affecting leukocyte development and autoimmunity.

Acute Coronary Syndrome Rates Elevated in Patients With RA Receiving bDMARDs

Recent studies suggest that a gap in cardiovascular risk remains between patients with rheumatoid arthritis and the general population.

Childhood Rheumatic Disease Negatively Impacts Standardized Test Scores

Limited physical function, fatigue, mental health issues (resulting from chronic disease), and medication issues can further affect the ability of children with rheumatic disease from performing well in school.




Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.